Back
Incyte 10K Form
Sell
40
INCY
Incyte
Last Price:
66.52
Seasonality Move:
15.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-30 | 10Q | INCY/Incyte Quarterly |
| 2023-10-31 | 10Q | INCY/Incyte Quarterly |
| 2023-08-01 | 10Q | INCY/Incyte Quarterly |
| 2023-05-02 | 10Q | INCY/Incyte Quarterly |
| 2022-11-01 | 10Q | INCY/Incyte Quarterly |
| 2022-08-02 | 10Q | INCY/Incyte Quarterly |
Receive INCY News And Ratings
See the #1 stock for the next 7 days that we like better than INCY
INCY Financial Statistics
Sales & Book Value
| Annual Sales: | $3.7B |
|---|---|
| Cash Flow: | $293.18M |
| Price / Cash Flow: | 895.98 |
| Annual Sales: | $16.45 |
| Price / Book: | 4.22 |
Profitability
| EPS (TTM): | 0.14000 |
|---|---|
| Net Income (TTM): | $32.48M |
| Gross Margin: | $3.44B |
| Return on Equity: | 0.75% |
| Return on Assets: | 0.54% |
Incyte Earnings Forecast
Key Incyte Financial Ratios
- The Gross Profit Margin over the past 31 years for INCY is 93.10%.
- The Selling, General & Administrative Expenses for INCY have been equal to 31.42% of Gross Profit Margin.
- The Research & Development expenses have been 44.04% of Revenue.
- The Interest Expense is 0.43% of Operating Income.
- The Net Earning history of INCY is 16.17% of Total Revenues.
- Per Share Earnings over the last 31 years have been positive in 18 years.
Incyte Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INCY |
| CUSIP: | 45337C |
| Website: | incyte.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.87 |
| Quick Ratio: | 1.69 |
Price-to-Earnings
| Trailing P/E Ratio: | 26.19 |
|---|---|
| Forward P/E Ratio: | 11.5 |